Naoto Cardiac Hypertrophy In Vitro and In Vivo Plays a Critical Role in Inhibition of γ Peroxisome Proliferator-Activated Receptor

Masayuki Asakawa, Hiroyuki Takano, Toshio Nagai, Hiroki Uozumi, Hiroshi Hasegawa, Naoto Cardiac Hypertrophy In Vitro and In Vivo Plays a Critical Role in Inhibition of γ Peroxisome Proliferator-Activated Receptor Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2002 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/hc1002.105225 2002;105:1240-1246; originally published online February 11, 2002; Circulation. http://circ.ahajournals.org/content/105/10/1240 World Wide Web at: The online version of this article, along with updated information and services, is located on the

[1]  P. Simpson,et al.  Differentiation of Rat Myocytes in Single Cell Cultures with and without Proliferating Nonmyocardial Cells: Cross‐Striations, infrastructure, and Chronotropic Response to Isoproterenol , 1982, Circulation research.

[2]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[3]  S. Sasayama,et al.  Phosphorylation of GATA-4 Is Involved in α1-Adrenergic Agonist-responsive Transcription of the Endothelin-1 Gene in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.

[4]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[5]  B. Spiegelman,et al.  Peroxisome proliferator–activated receptor γ ligands and atherosclerosis: ending the heartache , 2000 .

[6]  J Auwerx,et al.  The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. , 1996, Biochimica et biophysica acta.

[7]  IsseiKomuro,et al.  Calcineurin Plays a Critical Role in Pressure Overload–Induced Cardiac Hypertrophy , 1999 .

[8]  Y. Fujio,et al.  Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. , 1998, Circulation.

[9]  M. Sekiya,et al.  Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. , 1999, Journal of hypertension.

[10]  G. Paternostro,et al.  Insulin resistance in patients with cardiac hypertrophy. , 1999, Cardiovascular research.

[11]  P. Rowse,et al.  Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro. , 1998, Journal of cardiovascular pharmacology.

[12]  P. Libby,et al.  Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. , 1998, Circulation research.

[13]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[14]  D. Gardner,et al.  Divergent regulation of the human atrial natriuretic peptide gene by c-jun and c-fos , 1992, Molecular and cellular biology.

[15]  R. Kitsis,et al.  cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. , 1997, Circulation.

[16]  J. Holder,et al.  Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. , 1998, The Journal of pharmacology and experimental therapeutics.

[17]  I. Komuro,et al.  Peroxisome Proliferator–Activated Receptor Activators Inhibit Lipopolysaccharide-Induced Tumor Necrosis Factor-α Expression in Neonatal Rat Cardiac Myocytes , 2000 .

[18]  J. Molkentin,et al.  Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Jimenez-Linan,et al.  Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. , 1997, The Journal of clinical investigation.

[20]  IsseiKomuro,et al.  Rho Family Small G Proteins Play Critical Roles in Mechanical Stress–Induced Hypertrophic Responses in Cardiac Myocytes , 1999 .

[21]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[22]  B. Staels,et al.  Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. , 1999, Circulation research.

[23]  Y. Fujio,et al.  Activation of gp 130 Transduces Hypertrophic Signals via STAT 3 in Cardiac Myocytes , 1998 .

[24]  Satoshi Tanaka,et al.  PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .

[25]  J. Sadoshima,et al.  Critical Role of the AT1 Receptor Subtype , 2005 .

[26]  W. Hsueh,et al.  Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells , 2000 .

[27]  T. Quertermous,et al.  Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence. , 1990, The Journal of biological chemistry.

[28]  B. Seed,et al.  PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.

[29]  IsseiKomuro,et al.  Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice , 1998 .